Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Commission hears step‑2 assessments on prescription drug cost‑sharing and insulin/supplies caps; votes deferred after loss of quorum
Summary
The Bureau of Insurance presented step‑2 assessments on a prescription‑drug cost‑sharing limit and a proposal to cap insulin and diabetes supplies at $35; the commission deferred action after losing quorum.
The commission received two step‑2 assessments: one on a proposal to limit prescription‑drug cost sharing across plan tiers and another on House Bill 760 (as presented), which would cap insulin and diabetes equipment/supplies cost sharing at $35.
Mark Shipman of the Bureau of Insurance presented the step‑2 review on HB 946 (a proposal requiring at least 50% of plans in each rating area to cap prescription‑drug out‑of‑pocket costs at a fixed dollar amount). Shipman summarized carrier survey results about formulary tiers and reported an estimated premium impact of about…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
